Seizure disorder (epilepsy). A specific cannabidiol product (Epidiolex, GW Pharmaceuticals) has been shown to reduce seizures in adults and children with various conditions that are linked with seizures. This product is a prescription drug for treating seizures caused by Dravet syndrome or Lennox-Gastaut syndrome. It has also been shown to reduce seizures in people with tuberous sclerosis complex, Sturge-Weber syndrome, febrile infection-related epilepsy syndrome (FIRES), and specific genetic disorders that cause epileptic encephalopathy. But it's not approved for treating these other types of seizures.
After two decades of experience in the hemp industry, Paul Benhaim founded Elixinol – ostensibly, as the company’s website states, to “[manufacture] and [provide] the highest-quality CBD oil and hemp extracts in the world.” And so that CBD oil users can be assured of that quality, Elixinol extensively tests its extracts and provides certificates of analysis for its products that are available to view at a click. The manufacturer’s wares have even received a “stamp of approval” from The Realm of Caring Foundation, a Colorado-based non-profit and advocate for cannabinoid therapy research and education. Those wanting to assess Elixinol’s extracts for themselves can choose from its range of oral tinctures – with potencies of 300 mg, 600 mg and 3,600 mg – as well as topical balms and capsules. Plus, the company gives 5 percent of the proceeds from every sale to charity – so buyers may not only feel good after their purchases, but they’ll do some good, too.
The information above and any other communication regarding legality which you may receive from any representative of Green Roads or the Green Roads’ website is for informational purposes only and not for the purpose of providing legal advice. You must make your own judgment regarding whether you should purchase CBD in your jurisdiction. You should contact your attorney to obtain more specific guidance.*
While only 9 states currently have legalized recreational marijuana, as an industry weed has had a huge year of growth. This is in large part due to the increasing popularity of products that contain CBD in them. CBD, short for cannabidiol, is one of the hundreds of compounds found in the cannabis plant, and the potential it has shown in helping with pain, seizures and anxiety have made it a natural fit for medical and recreational weed alike.
There are so many different CBD products out there to choose from, and it can be difficult to find the ones that are just right for you. To help you make an informed decision and enjoy CBD’s benefits to the fullest, we have put together several pages of invaluable information about CBD, its properties, its uses, and how YOU can best benefit from it.
So, why are companies allowed to lie and mislead users trying to purchase CBD products? This a result of the industry lacking formal regulation. This is very controversial because it opens the doors for big pharmaceutical companies and lobbyists to get away with practices that may prevent CBD from becoming easily accessible to those who need it. Hopefully, legislation like the 2018 Farm Bill will help establish competitive practices in the industry that will benefit the consumer in the long run.
We also have to look at Federal spending budgets, don’t we? The Federal Appropriations that passed in April, 2017 specifically mentions the Department of Justice is prevented from “implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana.” Hemp is not medical marijuana, though one could assume if they’re not going after High-THC plants, they’re not going to go after low-THC plants either – especially without the budget needed.
It’s safe to say that Charlotte’s Web is probably the most recognized CBD brand out there — and it’s not all hype. This company pioneered the CBD industry and made it their mission to de-stigmatize CBD by setting the bar high for transparency. They produce and oversee their organic CBD products from seed to sale, standing behind them with a solid return policy.
Generalized pain, for instance, has dozens upon dozens of high profile research and clinical studies that have been carried out in universities and laboratories around the globe. One of the most well-publicized of these studies took place back in 2008, in which results determined that “cannabinoid analgesics (pain relievers) have generally been well tolerated in clinical trials … with acceptable adverse event profiles (meaning acceptable effectiveness for practical use).